KRAS and clear cell adenocarcinoma: KRAS mutations have been identified in 10–30% of endometrioid endometrial carcinomas [1, 2, 4, 7–12, 17] while some investigators have reported an almost complete absence of KRAS mutations in serous and clear cell carcinomas of endometrium [8].